|Bid||153.37 x 20200|
|Ask||130.42 x 293200|
|Day's range||141.76 - 142.75|
|52-week range||91.62 - 146.15|
|PE ratio (TTM)||48.59|
|Earnings date||14 Feb. 2018|
|Forward dividend & yield||1.44 (1.36%)|
|1y target est||107.45|
Here are three things you should look for with companies like Resapp Health Ltd (ASX:RAP) and Mustang Resources Ltd (ASX:MUS).
Shares in battled pharmaceutical company Mayne Pharma Group Ltd (ASX:MYX) rise on the back of positive announcements from rivals Teva and Mylan.
I think Altium Limited (ASX:ALU) shares could be a great long-term investment that helps you on your way to turning $10,000 into $1.5 million.
The CSL Limited (CSL:ASX) share price has doubled in the four years and three months since Paul Perreault became CEO. But some shareholders think he’s been paid too much.
CAMBRIDGE, Mass.--(BUSINESSWIRE)-- Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved AFLURIA QUADRIVALENT (Influenza Vaccine) for use in people five years of age and ...
RIGA, Latvia--(BUSINESSWIRE)-- Annual influenza-related hospitalizations among U.S. children younger than the age of 5 have ranged from 7,000 to 26,000 since 2010, and annual reported influenza-related ...
SUMMIT, N.J.--(BUSINESSWIRE)-- Seqirus announced today it has begun shipping its portfolio of seasonal influenza vaccines to customers in the United States for the 2017-2018 influenza season. Seqirus, ...
HOLLY SPRINGS, N.C.--(BUSINESSWIRE)-- Seqirus, a leading innovator in influenza vaccines and pandemic preparedness, today announced the next major advancement in the use of cell-based technology at its ...
January 5, 2017 --Momenta to receive $50 million upfront license fee and up to $550 million in potential milestone payments from CSL-- --Momenta to host a conference call for its investors today at CSL ...